דטסקאן

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

IOFLUPANE

Disponible desde:

ELDAN ELECTRONIC INSTRUMENTS CO LTD

Código ATC:

V09AB03

formulario farmacéutico:

תמיסה להזרקה

Composición:

IOFLUPANE 74 MBQ/ML

Vía de administración:

תוך-ורידי

tipo de receta:

מרשם נדרש

Fabricado por:

GE HEALTHCARE B.V., THE NETHERLAND

Grupo terapéutico:

OTHER DOPAMINERGIC AGENTS

Área terapéutica:

IODINE IOFLUPANE (123I)

indicaciones terapéuticas:

Datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - of patients with clinically uncertain Parkinsonian Syndromes in order to help differentiate Essential Tremor from Parkinsonian Syndromes related to idiopathic Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - Datscan is unable to discriminate between Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - To help differentiate probable dementia with Lewy bodies from Alzheimer's disease. Datscan is unable to discriminate between dementia with Lewy bodies and Parkinson's disease dementia

Fecha de autorización:

2014-11-30